Opinion.

A Structural Shift in Global Chemical and Pharma Infrastructure.

The East-to-West acquisition trend in chemicals and pharma validates a 10-year position. The evidence is in the numbers — Europe’s share of global chemical sales has fallen from 27% to 13%, China’s has risen from 10% to 46%, and India has gone from 1 to 46 billion-dollar chemical companies in 20 years.